Trial Profile
A retrospective study to evaluate clinical factors associated for the ustekinumab response in patients with psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 12 Dec 2015 New trial record